bioAffinity Technologies, Inc. Profile Avatar - Palmy Investing

bioAffinity Technologies, Inc.

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targe…

Medical - Diagnostics & Research
US, San Antonio [HQ]

Cash Flow Statements

Loading...
End of BIAF's Analysis
CIK: 1712762 CUSIP: 09076W109 ISIN: US09076W1099 LEI: - UEI: -
Secondary Listings
BIAF has no secondary listings inside our databases.